Source comparison
BPC-157 Pre-Cycle vs Post-Cycle Research: Protocol Comparison
Typical Dosing Window 5–7 days before stress induction; daily dosing to steady state Immediate post-injury; 7–14 days acute recovery phase Pre-cycle requires longer lead time but targets prevention; post-cycle focuses on repair velocity within a narrow therape
This comparison does not assign a generated winner or score.
- Typical Dosing Window
- 5–7 days before stress induction; daily dosing to steady state
- Immediate post-injury; 7–14 days acute recovery phase
- Pre-cycle requires longer lead time but targets prevention; post-cycle focuses on repair velocity within a narrow therapeutic window
- Primary Mechanism
- FAK/paxillin pathway activation; collagen cross-linking upregulation; growth factor receptor priming
- VEGF-driven angiogenesis; macrophage M1→M2 polarization; inflammatory cytokine suppression (IL-6, TNF-α)
- Mechanistically distinct. Pre-cycle builds structural resilience before load; post-cycle accelerates debris clearance and remodeling after damage
- Ideal Endpoints
- Tensile strength under load; time-to-failure; histological collagen density pre-stress
- Recovery velocity (strength return); inflammatory marker clearance (IL-6, TNF-α); capillary density restoration
- Endpoints must align with timing. Conflating them produces inconsistent replication because the biological question differs
- Typical Dose Range
- 250–500 mcg/kg subcutaneous or oral; sustained receptor occupancy prioritized
- 500 mcg–1 mg/kg subcutaneous/IM; acute high-dose to saturate inflammatory pathways
- Post-cycle often uses higher acute doses because the 24–72h inflammatory window is narrow; pre-cycle benefits from lower sustained dosing
- Common Research Errors
- Starting too close to stress event (< 5 days); insufficient priming time for FAK phosphorylation
- Measuring tensile strength (pre-cycle endpoint) in post-injury models; conflating repair quality with baseline integrity
- Timing mistakes undermine mechanistic clarity. The peptide's molecular action doesn't change, but the cellular context determines which pathways respond